ACC.26 Chair Kathryn Berlacher, MD, MS, explained some of the big trends at this year's meeting, including AI, CCTA, hands-on training and guideline sessions.

Lower Medicare drug costs translated into more patients taking their medications, leading to better outcomes.

New pacing system is designed to streamline TAVR cath lab workflows, cut procedural steps and increase reliability.

Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

More than 33,000 devices are affected by this recall. Customers may need to return and replace the purge cassettes included with their devices due to a risk of serious injury or death. 

Hadley Wilson, MD, a former American College of Cardiology president, spoke to Cardiovascular Business about several studies presented at ACC.26.

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.

A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.